Stay updated on BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial
Sign up to get notified when there's something new on the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page.

Latest updates to the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedMajor update: adds an operating-status notice and updates version to v3.2.0; removes the Follicular lymphoma resource (from GRDIC).SummaryDifference4%
- Check23 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%
- Check38 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the Back to Top link was removed. No substantive content changes are evident.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check52 days agoChange DetectedThe web page has undergone significant updates, including the addition of numerous facility names and locations, particularly in Russia and Ukraine, as well as the introduction of new medical terms related to blood proteins and lymphatic diseases. The previous version's references to certain locations and medical topics have been removed.SummaryDifference16%
- Check67 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page.